← FDA Drug Approvals (Drugs@FDA)
VENLAFAXINE BESYLATE
NDA · New Drug Application · Sponsor: ALMATICA · Approved 2022-06-29
Drug application
- FDA Application #
NDA215429- Application type
- New Drug Application
- Brand name
- VENLAFAXINE BESYLATE
- Generic name
- VENLAFAXINE
- Active ingredients
- VENLAFAXINE BESYLATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALMATICA
- Manufacturer
- Almatica Pharma LLC
- First approval
- 2022-06-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown